Scott R. VandenBerg

48.7k citations

152 papers · 11.9k indexed · 5 hit papers · h-index 56

Molecular Biology top 1%
Genetics top 0.05%
Cancer Research top 0.5%
Pulmonary and Respiratory Medicine top 1%
Oncology top 1%

Co-authors: Mitchel S. Berger Soonmee Cha M. Beatriz S. Lopes Gabriele Bergers Claudia Petritsch Radosław Rola John R. Fike Duncan Morhardt
Topics: Glioma Diagnosis and Treatment (49 papers)Protease and Inhibitor Mechanisms (11 papers)Neuroblastoma Research and Treatments (11 papers)
Cited by: Genetics Developmental Neuroscience Cancer Research
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Japan Switzerland

In The Last Decade

Scott R. VandenBerg

150 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

2008 904 citations Justin S. Smith, Kathleen R. Lamborn et al. profile →
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

2008 902 citations Kan Lu, Scott R. VandenBerg et al. profile →
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

2008 781 citations Mamie Yu, Scott R. VandenBerg et al. profile →
Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice

2004 584 citations Scott R. VandenBerg et al. profile →
Radiation-Induced Cognitive Impairments are Associated with Changes in Indicators of Hippocampal Neurogenesis

2004 581 citations Scott R. VandenBerg et al. profile →

Peers

Countries citing papers authored by Scott R. VandenBerg

Since Specialization

Citations

This map shows the geographic impact of Scott R. VandenBerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. VandenBerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. VandenBerg more than expected).

Fields of papers citing papers by Scott R. VandenBerg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. VandenBerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. VandenBerg. The network helps show where Scott R. VandenBerg may publish in the future.

Co-authorship network of co-authors of Scott R. VandenBerg

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. VandenBerg. A scholar is included among the top collaborators of Scott R. VandenBerg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. VandenBerg. Scott R. VandenBerg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence 2020 ·Journal of Mammary Gland Biology and Neoplasia ·Hidetoshi Mori,(unknown),(unknown),Pierre P. Massion,Clifford Hoyt,Scott R. VandenBerg,Laura J. Esserman,Alexander D. Borowsky,Michael J. Campbell	27
2	A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma 2014 ·Cancer Research ·Jill Wykosky,Jingjing Hu,German G. Gomez,(unknown),Genaro R. Villa,Donald Pizzo,Scott R. VandenBerg,Amy Haseley Thorne,Clark C. Chen,Paul S. Mischel,Steven L. Gonias,Webster K. Cavenee,Frank B. Furnari	43
3	Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM 2013 ·Frontiers in Oncology ·Nikdokht Farid,(unknown),Nathan S. White,Carrie R. McDonald,(unknown),Scott R. VandenBerg,Santosh Kesari,Anders M. Dale	25
4	Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies 2011 ·Cancer Research ·Jeonghee Cho,Sandra Pastorino,Qing Zeng,Xiaoyin Xu,(unknown),Scott R. VandenBerg,Roel G.W. Verhaak,Andrew D. Cherniack,Hideo Watanabe,Amit Dutt,Jihyun Kwon,Ying S. Chao,Robert C. Onofrio,Derek Y. Chiang,Yuki Yuza,Santosh Kesari,Matthew Meyerson	53
5	MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas 2011 ·Neuro-Oncology ·Inas S. Khayal,Scott R. VandenBerg,K. J. Smith,(unknown),Shannon Chang,Soonmee Cha,Sarah J. Nelson,Tracy R. McKnight	28
6	Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas 2010 ·Cancer Research ·Joshua D. Schiffman,John Hodgson,Scott R. VandenBerg,Patrick Flaherty,Mei‐Yin C. Polley,Mamie Yu,Paul G. Fisher,David H. Rowitch,James M. Ford,Mitchel S. Berger,Hanlee P. Ji,David H. Gutmann,C. David James	185
7	Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM 2010 ·Neuro-Oncology ·Radhika Srinivasan,Joanna J. Phillips,Scott R. VandenBerg,(unknown),(unknown),(unknown),Andrea Pirzkall,Soonmee Cha,Susan M. Chang,Sarah J. Nelson	35
8	Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival 2009 ·Journal of Neuro-Oncology ·Sean M. McBride,Daniel Pérez,Mei‐Yin C. Polley,Scott R. VandenBerg,Justin S. Smith,Shichun Zheng,Kathleen R. Lamborn,John K. Wiencke,Susan M. Chang,Michael D. Prados,Mitchel S. Berger,David Stokoe,Daphne A. Haas-Kogan	59
9	p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts 2008 ·Cancer Research ·Eduard B. Dinca,Kan Lu,Jann N. Sarkaria,Russell O. Pieper,Michael D. Prados,Daphne A. Haas‐Kogan,Scott R. VandenBerg,Mitchel S. Berger,C. David James	42
10	Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma 2007 ·Neuro-Oncology ·John K. Wiencke,Shichun Zheng,(unknown),Tarık Tihan,Scott R. VandenBerg,Tanja Tamgüney,(unknown),Ramon Parsons,Kathleen R. Lamborn,Mitchel S. Berger,Margaret Wrensch,Daphne A. Haas-Kogan,David Stokoe	123
11	In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas1 2007 ·Neuro-Oncology ·Michal Entin‐Meer,Xiaodong Yang,Scott R. VandenBerg,Kathleen R. Lamborn,Abraham Nudelman,Ada Rephaeli,Daphne A. Haas‐Kogan	45
12	Genome-wide Hypomethylation in Human Glioblastomas Associated with Specific Copy Number Alteration, Methylenetetrahydrofolate Reductase Allele Status, and Increased Proliferation 2006 ·Cancer Research ·Benoît Cadieux,Tsui‐Ting Ching,Scott R. VandenBerg,J Costello	178
13	Prolonged Survival in Carcinomatous Meningitis Associated With Breast Cancer 1995 ·Southern Medical Journal ·Paul L. Moots,(unknown),Scott R. VandenBerg	16
14	Differential Expression of Retinal Proteins in a Pineal Parenchymal Tumor 1993 ·Journal of Neuropathology & Experimental Neurology ·(unknown),F. Gonzalez–Fernandez,B. W. Scheithauer,Scott R. VandenBerg	20
15	Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases 1993 ·Cancer ·John E. Wanebo,Jacek M. Malik,Scott R. VandenBerg,Harold J. Wanebo,Naomi Driesen,John A. Persing	241
16	Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. 1992 ·PubMed ·F. Gonzalez–Fernandez,M. Beatriz S. Lopes,José M. Garcı́a-Fernández,F. Foster,W.J. De Grip,Sérgio Rosemberg,Steven A. Newman,Scott R. VandenBerg	40
17	Remote recurrence of craniopharyngioma in the epidural space 1992 ·Journal of neurosurgery ·Jacek M. Malik,(unknown),Scott R. VandenBerg	48
18	Electrophysiological findings in localized hypertrophic mononeuropathy 1991 ·Muscle & Nerve ·Lawrence H. Phillips,(unknown),Scott R. VandenBerg	26
19	Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets 1989 ·Life Sciences ·Scott R. VandenBerg,Steven L. Gonias	1
20	5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets 1989 ·Biochemical Pharmacology ·Scott R. VandenBerg,Steven G. Britt,Gerard T. Redpath,Steven L. Gonias	1

About Scott R. VandenBerg

Scott R. VandenBerg is a scholar working on Genetics, Developmental Neuroscience and Cancer Research, having authored 152 papers that have together received 11.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (49 papers), Protease and Inhibitor Mechanisms (11 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Genetics (4.5k citations), Developmental Neuroscience (1.3k citations) and Cancer Research (2.7k citations). Scott R. VandenBerg has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Mitchel S. Berger, Soonmee Cha, M. Beatriz S. Lopes, Gabriele Bergers, Claudia Petritsch, Radosław Rola, John R. Fike, Duncan Morhardt, Jacob Raber and Kathleen R. Lamborn. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact